Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

Proceedings of the National Academy of Sciences of the United States of America
Novalia PisheshaHidde L Ploegh

Abstract

Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance might overcome these obstacles. Here we use the transpeptidase sortase to covalently attach disease-associated autoantigens to genetically engineered and to unmodified red blood cells as a means of inducing antigen-specific tolerance. This approach blunts the contribution to immunity of major subsets of immune effector cells (B cells, CD4+ and CD8+ T cells) in an antigen-specific manner. Transfusion of red blood cells expressing self-antigen epitopes can alleviate and even prevent signs of disease in experimental autoimmune encephalomyelitis, as well as maintain normoglycemia in a mouse model of type 1 diabetes.

References

Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·P AicheleH Pircher
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·R S LiblauH O McDevitt
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·D TeitelbaumM Sela
Dec 18, 2003·Annals of the New York Academy of Sciences·George S Eisenbarth
Feb 1, 2005·Annals of the New York Academy of Sciences·Howard L Weiner
Jun 3, 2005·Nature·Marc Feldmann, Lawrence Steinman
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danielle M Turley, Stephen D Miller
Aug 11, 2007·Nature Reviews. Immunology·Stephen D MillerJoseph R Podojil
Sep 25, 2007·Nature Chemical Biology·Maximilian W PoppHidde L Ploegh
Oct 4, 2007·Annals of the New York Academy of Sciences·Francesca FerreraGilberto Filaci
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Richard A O'ConnorStephen M Anderton
Apr 15, 2009·Nature Reviews. Immunology·Douglas R GreenGuido Kroemer
Jun 24, 2011·Proceedings of the National Academy of Sciences of the United States of America·Irwin ChenDavid R Liu
Aug 9, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R GettsStephen D Miller
Sep 3, 2011·Blood·Marie-Catherine GiarratanaLuc Douay
Nov 1, 2011·Immunity·Thomas S Griffith, Thomas A Ferguson
Feb 22, 2012·Traffic·Karin StrijbisHidde L Ploegh
Jun 26, 2012·Biotechnology and Bioengineering·Hidehiko HirakawaTeruyuki Nagamune
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephanie K DouganHidde L Ploegh
Dec 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephan KontosJeffrey A Hubbell
Jan 12, 2013·International Journal of Pharmaceutics·Magali CremelYann Godfrin
Jun 7, 2013·Science Translational Medicine·Andreas LutterottiRoland Martin
Aug 16, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sabine RingKarsten Mahnke
Oct 15, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Charles L HardyMagdalena Plebanski
Feb 5, 2014·The Journal of Experimental Medicine·Ana M AvalosHidde L Ploegh
Feb 7, 2014·Annual Review of Immunology·Emil R Unanue
Jul 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jiahai ShiHarvey F Lodish
May 29, 2015·Science Translational Medicine·Mahzad AkbarpourMaria Grazia Roncarolo
Jul 25, 2015·Nature Reviews. Immunology·E John Wherry, Makoto Kurachi
Oct 30, 2015·Scientific Reports·Alizée J GrimmJeffrey A Hubbell
Nov 26, 2015·Science Advances·Kristen M LorentzJeffrey A Hubbell
Mar 2, 2016·Annual Review of Biomedical Engineering·Xunrong LuoLonnie D Shea

❮ Previous
Next ❯

Citations

Mar 24, 2017·Science Translational Medicine·Kathryn Dupnik
Jan 18, 2018·Chemistry : a European Journal·Xiaobao BiChuan-Fa Liu
Sep 7, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jessica R IngramMichael Dougan
Aug 2, 2017·American Journal of Hematology·Mauro Magnani
Aug 16, 2018·Annual Review of Cell and Developmental Biology·Novalia PisheshaHidde L Ploegh
Jan 4, 2019·Advanced Healthcare Materials·Joshua M Gammon, Christopher M Jewell
Nov 8, 2019·Blood Advances·Steven HeshusiusEmile van den Akker
Aug 15, 2017·Current Opinion in Hematology·Lyla A Youssef, Steven L Spitalnik
Jun 4, 2020·Brain Sciences·Olga Kammona, Costas Kiparissides
Feb 26, 2019·Nature Biotechnology·Pau Serra, Pere Santamaria
Jul 16, 2020·Proceedings of the National Academy of Sciences of the United States of America·Anvay UkidveSamir Mitragotri
Sep 5, 2019·Frontiers in Physiology·Luigia RossiMauro Magnani
Apr 17, 2020·Frontiers in Immunology·José M CarballidoMichael Kammüller
Jun 27, 2019·Advanced Therapeutics·R S OakesC M Jewell
Nov 11, 2020·Current Diabetes Reports·Jeniffer D Loaiza NaranjoEmma E Hamilton-Williams
Nov 13, 2020·Biomaterials Science·Amy E EmersonJessica D Weaver
Dec 22, 2020·Trends in Pharmacological Sciences·Lucas M BushTara L Deans
Jan 16, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Peter Y LiHao Cheng
Feb 7, 2021·Current Diabetes Reports·Ethan J BassinSteven R Little
Jan 24, 2021·Immunology and Cell Biology·Silvia Rodriguez-FernandezMarta Vives-Pi
Nov 3, 2020·Frontiers in Immunology·Laura Passerini, Silvia Gregori
Jan 23, 2021·International Journal of Molecular Sciences·Francesca AglialoroEmile van den Akker
Sep 19, 2020·Advanced Drug Delivery Reviews·Flávia CastroBruno Sarmento
Mar 17, 2021·Molecular Therapy. Methods & Clinical Development·Magnus A G HoffmannPamela J Bjorkman
Mar 17, 2021·European Journal of Pharmacology·Nur Najihah Izzati Mat RaniMohd Cairul Iqbal Mohd Amin
Apr 4, 2020·Cell·Zongmin ZhaoSamir Mitragotri
Apr 8, 2019·The Journal of Allergy and Clinical Immunology·Emma Guttman-YasskyJames G Krueger
Jun 16, 2021·ACS Chemical Biology·Thibault J HarmandHidde L Ploegh
Jun 25, 2021·Frontiers in Immunology·Anna TorunBeata Pyrzynska
Apr 1, 2021·Annual Review of Biomedical Engineering·Jacob S BrennerVladimir R Muzykantov
Jul 25, 2021·International Journal of Molecular Sciences·Inez WensNathalie Cools
Aug 9, 2021·Advanced Drug Delivery Reviews·Guangna LiuGuangjun Nie

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.